We are live on ! Find out more
WINT

Windtree Therapeutics
WINT

Delisted

WINT was delisted on the 20th of August, 2025.

Back to rankings

6 hedge funds and large institutions have $4M invested in Windtree Therapeutics in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

113% more capital invested

Capital invested by funds: $1.88M → $4M (+$2.12M)

50% more funds holding

Funds holding: 4 → 6 (+2)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.02M
2
Millennium Management
Millennium Management
New York
+$1.01M
3
Northern Trust
Northern Trust
Illinois
+$336K
4
PP
Paloma Partners
Connecticut
+$336K

Top Sellers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
-$226K
2
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$7

WINT Hedge Fund Activity: Q3 2020 in Review

6 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics (WINT) for Q3 2020, worth a combined $4M — up 113% from $1.88M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new WINT positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $2.02M. The largest seller was CVI Holdings, exiting entirely with an estimated $226K sold.

  • 6 institutional investors held Windtree Therapeutics (WINT) as of Q3 2020, up from 4 in Q2 2020.
  • Funds reported $4M of Windtree Therapeutics stock for Q3 2020, up 113% quarter-over-quarter.
  • 3 funds opened new Windtree Therapeutics positions in Q3 2020 and 1 closed out, a net change of +2 holders.
  • The largest Windtree Therapeutics buyer in Q3 2020 was Vanguard Group, an estimated $2.02M added.
  • The largest Windtree Therapeutics seller in Q3 2020 was CVI Holdings, an estimated $226K sold.

Based on aggregated 13F filings for Q3 2020.